Clinical Trial Update: Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether tart cherry juice can prevent paclitaxel-induced neuropathy in patients with breast or ovarian cancer. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Tart cherry juice

Snippet

Sponsor: University of California, Davis | Conditions: Breast Cancer, Breast Cancer Stage I | Phase 2 | Status: RECRUITING